Health ❯ Public Health ❯ Infectious Diseases ❯ HIV/AIDS

Prevention Strategies

Deals Set $40 Generics of Twice-Yearly HIV Prevention Shot for 120 Countries by 2027

Upfront financing plus volume commitments aim to accelerate manufacturing before wider rollouts.

UN Warns US Aid Suspension Risks Reversing Global HIV Progress

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention